自噬是胰腺星状细胞活化所必需,与胰腺癌进展相关并促进小鼠胰腺肿瘤生长
研究分析133例日本胰腺切除标本,发现胰腺星状细胞(PSC)自噬与肿瘤T分期、组织学分级、淋巴结转移、分期、淋巴管侵犯和血管侵犯显著相关,且与患者生存期缩短和疾病复发相关。抑制PSC自噬可增加脂滴、减少ECM分子和白细胞介素6产生及增殖侵袭,并使裸鼠肿瘤更小、肝转移和腹膜播散更少。
要点
- PSC自噬与胰腺癌T分期、组织学分级、淋巴结转移、分期、淋巴管侵犯和血管侵犯显著相关。
- PSC表达微管相关蛋白1轻链3与患者生存期缩短和疾病复发相关,缩短生存的相对危险度为1.56。
- 抑制PSC自噬可增加脂滴、减少ECM分子和白细胞介素6产生及增殖侵袭,并减少裸鼠肿瘤生长、肝转移和腹膜播散。
核心结论
- 自噬的PSC产生ECM分子和白细胞介素6,与胰腺癌患者生存期缩短和疾病复发相关。
- PSC自噬抑制剂可能通过改变肿瘤间质来降低胰腺肿瘤的侵袭性。
研究设计与样本
- 研究纳入2000年至2009年在日本接受胰腺切除术的133例胰腺肿瘤标本,进行免疫荧光显微镜和免疫组织化学分析。
- PSC从胰腺肿瘤组织或慢性胰腺炎患者组织培养,通过免疫荧光显微镜、免疫印迹、定量逆转录聚合酶链反应及侵袭性、增殖和脂滴实验分析。
- 通过给予氯喹或转染小干扰RNA抑制PSC自噬,通过表达短发夹RNA在永生化PSC中敲低蛋白。
- 将细胞移植到裸鼠胰腺尾部,定量肿瘤生长和转移。
主要发现
- 免疫组化分析显示,自噬与肿瘤T分期(P = .018)、组织学分级(P = .001)、淋巴结转移(P < .001)、分期(P = .009)、淋巴管侵犯(P = .001)和血管侵犯(P = .003)显著相关。
- PSC自噬与胰腺癌患者生存期缩短相关;PSC表达微管相关蛋白1轻链3与患者不良结局(生存期缩短、疾病复发)相关,缩短生存的相对危险度为1.56。
- 免疫印迹显示,胰腺肿瘤样本来源的PSC自噬标志物表达水平高于慢性胰腺炎样本来源的PSC。
- 自噬抑制剂增加PSC脂滴数量(指示静息状态),并减少ECM分子和白细胞介素6产生以及体外增殖和侵袭性。
- 与未暴露于自噬抑制剂的PSC相比,暴露于自噬抑制剂的PSC在裸鼠中形成更小的肿瘤(P = .001)、更少的肝转移(P = .018)和更少的腹膜播散(P = .018)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Pancreatic stellate cells (PSCs) change from a quiescent to activated state in the tumor environment and secrete extracellular matrix (ECM) molecules and cytokines to increase the aggressiveness of tumors. However, it is not clear how PSCs are activated to produce these factors, or whether this process can be inhibited. PSCs have morphologic and functional similarities to hepatic stellate cells, which undergo autophagy to promote fibrosis and tumor growth. We investigated whether autophagy activates PSCs, which promotes development of the tumor stroma and growth of pancreatic tumors in mice. METHODS: We used immunofluorescence microscopy and immunohistochemistry to analyze pancreatic tumor specimens from 133 patients who underwent pancreatectomy in Japan from 2000 to 2009. PSCs were cultured from pancreatic tumor tissues or tissues of patients with chronic pancreatitis; these were analyzed by immunofluorescence microscopy, immunoblots, quantitative reverse transcription polymerase chain reaction, and in assays for invasiveness, proliferation, and lipid droplets. Autophagy was inhibited in PSCs by administration of chloroquine or transfection with small interfering RNAs. Proteins were knocked down in immortalized PSCs by expression of small hairpin RNAs. Cells were transplanted into pancreatic tails of nude mice, and tumor growth and metastasis were quantified. RESULTS: Based on immunohistochemical analyses, autophagy was significantly associated with tumor T category (P = .018), histologic grade (P = .001), lymph node metastases (P < .001), stage (P = .009), perilymphatic invasion (P = .001), and perivascular invasion (P = .003). Autophagy of PSCs was associated with shorter survival times of patients with pancreatic cancer. PSC expression of microtubule-associated protein 1 light chain 3, a marker of autophagosomes, was associated with poor outcomes (shorter survival time, disease recurrence) for patients with pancreatic cancer (relative risk of shorter survival time, 1.56). Immunoblots showed that PSCs from pancreatic tumor samples expressed higher levels of markers of autophagy than PSCs from chronic pancreatitis samples. Inhibitors of autophagy increased the number of lipid droplets of PSCs, indicating a quiescent state of PSCs, and reduced their production of ECM molecules and interleukin 6, as well as their proliferation and invasiveness in culture. PSCs exposed to autophagy inhibitors formed smaller tumors in nude mice (P = .001) and fewer liver metastases (P = .018) with less peritoneal dissemination (P = .018) compared to PSCs not exposed to autophagy inhibitors. CONCLUSIONS: Autophagic PSCs produce ECM molecules and interleukin 6 and are associated with shorter survival times and disease recurrence in patients with pancreatic cancer. Inhibitors of PSC autophagy might reduce pancreatic tumor invasiveness by altering the tumor stroma.
引用
- Endo S, Nakata K, Ohuchida K, et al. Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice. Gastroenterology. 2017. PMID: 28126348. doi:10.1053/j.gastro.2017.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。